For more than 135 years, Johnson & Johnson has been dedicated to addressing some of the world's toughest health challenges.
Johnson & Johnson has been relentlessly driving toward that goal through such efforts as its groundbreaking work to help eliminate cancer, its support of health equity solutions and its pandemic response.
In 2021, Johnson & Johnson's COVID-19 vaccine received Emergency Use Authorization from the U.S. Food and Drug Administration. That same year, the Janssen Pharmaceutical Companies of Johnson & Johnson also had two new product approvals, including one for relapsing forms of multiple sclerosis. The other, for non-small cell lung cancer for patients with a specific genetic mutation, is just one example of how the company is making progress toward its vision of a world without cancer.
Johnson & Johnson has always aimed to put a world of well within reach of everyone, everywhere. It is honored to be named one of Fortune's World's Most Admired Companies once again.